INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Aug 24, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,741 | $592.27 | 94,615 |
Sep 14, 2011 |
Director
Trans History: 547
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | $24.41 | 94,736 |
Sep 13, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $16.59 | 94,758 |
Dec 13, 2013 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 95,000 | -- | 95,000 |
Aug 20, 2020 |
EVP & General Mgr Industrial O
Trans History: 359
|
EVP & General Mgr Industrial O | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 75,000 | $179.13 | 95,001 |
Sep 13, 2009 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $16.58 | 95,058 |
Sep 13, 2006 |
Director, Chief Exec Officer & President, Ten Percent Owner
Trans History: 427
|
Director, Chief Exec Officer & President, Ten Percent Owner | Form 4/A | Open market or private sale of non-derivative or derivative security | 200 | $16.58 | 95,058 |
Aug 25, 2020 |
Director
Trans History: 326
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 400 | $602.68 | 95,065 |
Dec 18, 2006 |
SVP, Therap & Clin Prog Dev
Trans History: 660
|
SVP, Therap & Clin Prog Dev | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 95,079 | -- | 95,079 |
Nov 13, 2012 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 198 | $146.60 | 95,159 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.